What AREDS2 actually measured
AREDS2 randomised 4,203 people with intermediate AMD, or advanced AMD in one eye, to formulas with and without lutein and zeaxanthin. The tested dose was 10 mg lutein and 2 mg zeaxanthin, added to the original AREDS vitamins: C 500 mg, E 400 IU, zinc 80 mg, copper 2 mg. The beta-carotene in the original formula was removed in the same trial.
The outcome was progression to advanced AMD — a clinical event, measured over five years. That is the strongest kind of evidence a supplement can have, and it belongs specifically to 10 mg plus 2 mg inside that complete formula. It does not automatically transfer to 20 mg, and it does not transfer to a lutein-only product.
What the 20 mg evidence measured
The case for 20 mg rests on a different endpoint: macular pigment optical density, or MPOD. It is a measurement of how much carotenoid has actually accumulated in the macula, taken with a heterochromatic flicker photometer or similar instrument. Higher density means a thicker optical filter in front of the photoreceptors.
Dose-response work has consistently found that 20 mg raises MPOD further than 10 mg, and that responses flatten above roughly 20 mg. A meta-analysis of 20 randomised trials confirmed that lutein supplementation raises MPOD, with larger effects at doses of 15 mg and above.
The honest caveat: MPOD is a surrogate. It is a plausible mechanism and it correlates with visual function in observational work, but no large trial has taken the next step and shown that pushing MPOD higher with 20 mg prevents more AMD than 10 mg does. The chain of reasoning is good. It is still a chain.
So which should you take?
It depends on what you are trying to do, and the two situations are genuinely different:
| Situation | The defensible choice | Why |
|---|---|---|
| Diagnosed intermediate AMD | The full AREDS2 formula, 10 mg + 2 mg | It is the only thing tested. A 20 mg lutein-only product omits four of the six nutrients. |
| Family history, no diagnosis | Either dose, with realistic expectations | No trial shows prevention in healthy eyes at any dose. 20 mg is a reasonable choice on the pigment evidence. |
| Low measured MPOD | 20 mg, ideally with all three carotenoids | This is the endpoint the higher dose actually moves. |
| Already taking a multivitamin with lutein | Check the total, do not stack blindly | Two products can add up past 40 mg without anyone noticing. |
Safety at 20 mg
Lutein has no established tolerable upper intake level from EFSA or the NIH. Studies have used 20 mg daily for six to twelve months without adverse effects. The one consistently reported effect at high intake is carotenodermia — a yellowing of the skin that is cosmetic and reverses when intake drops.
The safety question is not really about lutein. It is about what else is in the bottle: zinc without copper, very high vitamin E, or beta-carotene in someone with a smoking history. Those are the ingredients that carry risk, and they are printed on the same panel.
What the labels actually offer
We read the panels of 14 eye supplements. On lutein dose alone, the market splits three ways:
- 10 mg — the trial dose: PreserVision AREDS 2, Viteyes Classic, MacuHealth Triple Carotenoid, 1MD VisionMD, Life Extension MacuGuard.
- 20 mg or more: iGenics (20 mg), Puritan's Pride (20 mg), Nutricost (20 mg), NOW Foods (25 mg).
- Undisclosed: VisiFlora places its carotenoids inside a 351 mg proprietary blend with no individual doses printed.
The dose is only half of it. A product can print 20 mg of lutein and 0.8 mg of zeaxanthin, which moves it further from the trial ratio than any 10 mg product on the list. The ratio is on the panel; nobody puts it on the front.